top of page
At the Pharmacy

Distribution

Introducing Global Market opportunities

Building on our patented, game-changing technology and its ability to accelerate the body’s own natural processes, DREAMADERM has secured significant wholesale, retail and healthcare distribution in multiple markets. As a “Made in USA” ingredient, products containing Dermatrix will support higher profit margins. The Mexico initial conservative points-of-sale commitments will drive immediate revenues while allowing significant and achievable regional scaling capabilities.

1-a

Wound Healing

Acute

Viral 

Blister

Chronic

1-a

Aesthetic

Treatment

Recovery

OTC General Wound Healing

Phase 1a

Acute

Liquid Bandage Chronic

OTC Targeted Wound Healing

Phase 1b

Burn Blister Friction Blister Viral Blister

OTC Home Aesthetics

Phase 2

Micro-Needle Meso-Needle Viral Blister

Spa Aesthetics

Phase 3

Micro-Needle

Meso-Needle

Ablative Recovery 

Advanced Aesthetics

Phase 4

Fillers 

Botulinum Toxins

PDO Threads 

PLLA 

PRP

Advanced Medical / Aesthetics

Phase 5

Severe Burns 

Diabetic Wounds

image.png

Initial

Mexico

Korea/Asia

 USA

Phase in

South America

Middle east

Europe

Market Size

The global peptide therapeutics market size was estimated at $43.11 billion in 2022 and is expected to reach $76.83 billion by 2032

5.94% CAGR from 2023 to 2032

Wound Healing  $23B projected market by 2027

Skin care world wide $150B projected market by 2027

Screenshot (15).png
Screenshot (13).png

 Global Market 

Diabetes Market Size

Capture.PNG

Diabetes Causes at least $966B in health expenditure

Overall, global diabetes-related health expenditure is estimated to rise to $1054B by 2045

Screenshot (17).png

Business Model

Initial Distribution

Mexico Manufacturing & Distribution

130M

Population

51M

Annual Tourism

Korea Manufacturing & Distribution

52M

Population

Global

Skincare Epicente

USA Manufacturing & Distribution

335M

Population

45M

Annual Tourism

bottom of page